Yang Xing-Yu, Zhang Xiao, Cao Jun-Feng, Wu Mei, Chen Sheng-Yan, Chen Li
School of Clinic Medicine Chengdu Medical College Chengdu Sichuan China.
School of Basic Medicine Chengdu Medical College Chengdu Sichuan China.
Ibrain. 2023 Aug 6;9(3):326-339. doi: 10.1002/ibra.12122. eCollection 2023 Fall.
Cerebral ischemia is a serious cerebrovascular disease with the characteristics of high morbidity, disability, and mortality. Currently, stem cell therapy has been extensively applied to a wide range of diseases, including neurological disorders, autoimmune deficits, and other diseases. Transplantation therapy with neural stem cells (NSCs) is a very promising treatment method, which not only has anti-inflammatory, antiapoptotic, promoting angiogenesis, and neurogenesis effects, but also can improve some side effects related to thrombolytic therapy. NSCs treatment could exert protective effects in alleviating cerebral ischemia-induced brain damage and neurological dysfunctions. However, the different injection routes and doses of NSCs determine diverse therapeutic efficacy. This review mainly summarizes the various injection methods and injection effects of NSCs in cerebral ischemia, as well as proposes the existing problems and prospects of NSCs transplantation.
脑缺血是一种严重的脑血管疾病,具有高发病率、高致残率和高死亡率的特点。目前,干细胞疗法已广泛应用于多种疾病,包括神经系统疾病、自身免疫缺陷及其他疾病。神经干细胞(NSCs)移植治疗是一种非常有前景的治疗方法,它不仅具有抗炎、抗凋亡、促进血管生成和神经发生的作用,还能改善与溶栓治疗相关的一些副作用。NSCs治疗在减轻脑缺血诱导的脑损伤和神经功能障碍方面可发挥保护作用。然而,NSCs不同的注射途径和剂量决定了不同的治疗效果。本文综述主要总结了NSCs在脑缺血中的各种注射方法及注射效果,并提出了NSCs移植存在的问题及前景。